Gyldendal ASA

Gyldendalprisen 2023 til Hanne Ørstavik18.4.2024 13:17:19 CEST | Gyldendal ASA

Vinneren av Gyldendalprisen 2023 er Hanne Ørstavik (f.1969), en av vår tids mest markante og særpregete forfattere. Ørstavik debuterte med romanen Hakk i 1994, og har utgitt til sammen fjorten romaner. Hun har mottatt en rekke litterære priser, blant andre Brageprisen, Sultprisen, P2-lytternes romanpris, Amalie Skram-prisen, Oktoberprisen, Doblougprisen og Aschehougprisen. Ørstaviks bøker er oversatt til over 30 språk.

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria18.4.2024 10:15:00 CEST | news aktuell GmbH

Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. PCR test for multiresistant gram-negative (MRGN) bacteria to be developed using novel BioMEMS technology. BioMEMS chips permit simultaneous testing of up to 250 genetic characteristics – in some cases, in less than 15 minutes. Darmstadt, Gerlingen, and Waiblingen, Germany – The market for medical technology is innovative, dynamic, and growing. Bosch sees medical technology as a strategic growth field and intends to expand its Bosch Healthcare Solutions subsidiary, based in Waiblingen. Bosch has now entered into a new partnership with the German diagnostics solutions company R-Biopharm. This partnership will be focused on Bosch’s universal, fully automated Vivalytic molecular diagnostic analysis platform. The two companies will invest a total of 150 million euros by the end of the decade. Within their strategic development and distribution partnership, the partners intend t
  • 1
  • 2
  • 3
  • 4
  • 5
  • Siste
  • >>
HiddenA line styled icon from Orion Icon Library.Eye